Pharmadrama – it’s not what you do it’s the way that you do it @EFPIA @PMLiVEcom

This is a brief one. EFPIA - the European Federation for Pharmaceutical Industries and Associations - has this morning launched a manifesto for putting pharma at the heart of evonomic growth in the European Union (EU). It's a comprehensive tome. With laudable recommendations and objectives on many things I would agree with it on... Continue Reading →

Patients need apply – European Medicines Agency (EMA) next steps on clinical trial data

The European Medicines Agency (EMA) has published the note of the conference held in London a few weeks ago, about its plans for proactive publication of clinical trial data. It is now setting up five advisory groups and inviting self-nominations from people to join these.  You will find the following listing of the advisory groups, plus... Continue Reading →

Regulators push openness agenda on raw trial data…and EUPATI issues call for examples of educational materials on medicines development

Yes, that is a long headline is it not?  PharmaTimes and others cover a paper in PloS Medicine authored by a number of medicines regulators including the European Medicines Agency (EMA), calling for openness in raw trial data. The three pronged approach they suggest looks like a good basis for discussion.  It would be interesting... Continue Reading →

Blog at

Up ↑

%d bloggers like this: